中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [11]
合肥物质科学研究院 [11]
武汉物理与数学研究所 [1]
自动化研究所 [1]
上海生物化学与细胞生... [1]
采集方式
OAI收割 [25]
内容类型
期刊论文 [25]
发表日期
2023 [2]
2022 [2]
2021 [5]
2020 [6]
2019 [1]
2018 [3]
更多
学科主题
Oncology [1]
筛选
浏览/检索结果:
共25条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer
期刊论文
OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 13
作者:
Zhou, Ji
;
Zhang, Xu-Chao
;
Xue, Shan
;
Dai, Mengdi
;
Wang, Yueliang
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2023/10/17
Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells
期刊论文
OAI收割
Signal Transduction and Targeted Therapy, 2023, 卷号: 8, 期号: 6, 页码: 3013-3028
作者:
Wang, Ziruoyu
;
Li, Yanan
;
Zhao, Wensi
;
Jiang, Shuai
;
Huang, Yuqi
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2024/03/27
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
OAI收割
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
  |  
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements
期刊论文
OAI收割
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:
Zhang, Yongchang
;
Huang, Zhe
;
Zeng, Liang
;
Zhang, Xiangyu
;
Li, Yizhi
  |  
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2022/05/05
Quality of Life and Subgroup Analysis in a Phase 3 Randomized Study of Ensartinib vs Crizotinib in ALK-Positive NSCLC Patients: eXalt3.
期刊论文
OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:
Selvaggi, G.
;
Wu, Y.
;
Wang, Z.
;
Wu, G.
;
Poddubskaya, E.
  |  
收藏
  |  
浏览/下载:119/0
  |  
提交时间:2021/05/17
ALK
NSCLC
ensartinib
Noncanonical Gene Fusions Detected at the DNA Level Necessitate Orthogonal Diagnosis Methods Before Targeted Therapy
期刊论文
OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:
Song, Zhengbo
;
Lu, Chenyu
;
Xu, Chun-Wei
;
Zheng, Zongli
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2021/05/17
Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:
Cai, Lei
;
Wang, Jiangfeng
;
Yan, Junrong
;
Zeng, Jian
;
Zhu, Liang
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2021/03/15
invasive mucinous adenocarcinoma
surgical resection
next generation sequencing
genomic profiling
prognostic biomarker
Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:
Cai, Lei
;
Wang, Jiangfeng
;
Yan, Junrong
;
Zeng, Jian
;
Zhu, Liang
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2021/03/15
invasive mucinous adenocarcinoma
surgical resection
next generation sequencing
genomic profiling
prognostic biomarker
A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib
期刊论文
OAI收割
CLINICAL LUNG CANCER, 2021, 卷号: 22
作者:
Chen, Kaiyan
;
Zhang, Fanrong
;
Pan, Guoqiang
;
Sheng, Jiamin
;
Ye, Junyi
  |  
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2021/03/15
Crizotinib
MET
Non-small-cell lung cancer
RET
Resistance
Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3
期刊论文
OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15
作者:
Selvaggi, G.
;
Wakelee, H. A.
;
Mok, T.
;
Wu, Y. -L.
;
Reck, M.
  |  
收藏
  |  
浏览/下载:127/0
  |  
提交时间:2020/11/30
ALK plus NSCLC
ensartinib
Crizotinib